Uni-Bio Science Group Announces 2024 Interim Results
Achiev ed Record High Revenue of HK$ 273.6M and Net Profit of HK$ 67 .4M Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets HONG KONG SAR - EQS Newswire - 28 August 2024 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.H
read full article
